Chinese herbal medicine in the treatment of chronic heart failure: Three-stage study protocol for a randomized controlled trial

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Luo, Liangtao ^a,b   Chen, Jianxin ^a   Guo, Shuzhen ^a   Wang, Juan ^a   Gao, Kuo ^a   Zhang, Peng ^a,c   Chen, Chan ^a,d   Zhao, Huihui ^a   Wang, Wei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^d Hangzhou Hospital of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT; PLACEBO;

ADULT; ARTICLE; BLOOD EXAMINATION; BLOOD STASIS (DISEASE); CHEQIANZI; CHINESE MEDICINE; CHISHAO; CODONOPSIS PILOSULA; COMMUNITY CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HERB; HERBAL MEDICINE; HONGHUA; HUANGQI; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHLEGM SYNDROME; PHYSICAL DISEASE BY BODY FUNCTION; POLYPORUS UMBELLATUS; PRIORITY JOURNAL; QI DEFICIENCY; RANDOMIZED CONTROLLED TRIAL; ROUGUI; SALVIA MILTIORRHIZA; SYNDROME; TAOREN; TINGLIZI; UNSPECIFIED SIDE EFFECT; WATER RETENTION (DISEASE); YANG DEFICIENCY; ZEXIE; ZHIFUZI;

EID: 84930679718     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/927160     Document Type: Article

References (13)

1. K. Dickstein, A. Cohen-Solal, G. Filippatos et al., "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)," European Journal of Heart Failure, vol. 10, pp. 933-989, 2008.
2. D. F. Gu, G. Y. Huang, J. He et al., "Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population," Chinese Journal of Cardiology, vol. 1, pp. 3-6, 2003.
3. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., "Heart disease and stroke statistics-2012 update: a report from the American Heart Association," Circulation, vol. 125, no. 1, pp. e2-e220, 2012.
4. National Institutes of Health and National Heart-Lung-and Blood Institute, Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases, 2012.
5. Chinese Society of Cardiology of Chinese Medical Association and Editorial Board of Chinese Journal of Cardiology, "Guidelines for the diagnosis and management of chronic heart failure," Chinese Journal of Cardiology, vol. 12, pp. 1076-1095, 2007.
6. C. W. Yancy, M. Jessup, B. Bozkurt et al., "2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/american heart association task force on practice guidelines," Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147-e239, 2013.
7. Y. L. Wu, C. H. Gu, G. C. Xu, C. Wei, and X. D. Gao, "Clinical observation of randomized double-blind and multicenter trial on Qiliqiangxin capsule in the treatment of chronic heart failure," Chinese Journal of Difcult and Complicated Cases, vol. 5, pp. 263-266, 2007.
8. Y.-Z. Hou, J.-Y. Mao, X.-L. Wang, J. Li, and C.-X. Liu, "Shenfu injection for patients with heart failure: a systematic review," Chinese Journal of Evidence-Based Medicine, vol. 11, no. 3, pp. 292-299, 2011.
9. Y. Z. Hou, J. Y. Mao, X. L. Wang, C. X. Liu, and C. Zhang, "Shenmai injection in heart failure patients: a systematic review and meta-analysis," Chinese Journal of Evidence-Based Medicine, vol. 10, no. 8, pp. 939-945, 2010.
10. Z. Peng, Study of Distribution Regularities of Common Traditional Chinese Medicine Syndromes and Syndrome Factors in Patients with Chronic Heart Failure Caused by Coronary Heart Disease, Beijing University of Chinese Medicine, Beijing, China, 2011.
11. Association NYH, Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis, Little, Brown, 1964.
12. X. Y. Zheng, The Guiding Principles for the Clinical Study of New Drugs for Use in Traditional Chinese Medicine (In Trying), Chinese Medical Science and Technology Press, 2002.
13. X. Li, J. Zhang, J. Huang et al., "A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efects of qili qiangxin capsules in patients with chronic heart failure," Journal of the American College of Cardiology, vol. 62, no. 12, pp. 1065-1072, 2013.